Minimally invasive musculoskeletal ultrasound provides a fast, accurate diagnosis of rheumatic diseases, among other benefits, researchers said.
Minimally invasive musculoskeletal ultrasound provides a fast, accurate diagnosis of rheumatic diseases - plus better measurement of treatment success, reduced procedural pain, and improved patient satisfaction.
"With so many people affected by rheumatic diseases, including arthritis, a diagnostic tool such as MSUS that is minimally invasive and with little risk to patients is an important tool for rheumatologists," said Tim McAlindon, MD, of Tufts Medical Center in Boston, Mass., lead researcher for a study published online in Arthritis Care & Research.
McAlindon’s task force reviewed the literature for recommendations on the use of MSUS and found evidence for several applications. A few examples include:
• further investigation into articular pain, swelling, or mechanical symptoms without definitive diagnosis on clinical exam;
• further investigation of current or new inflammatory arthritis symptoms, shoulder pain or mechanical symptoms to evaluate underlying structural disorders, but not for adhesive capsulitis or as preparation for surgical intervention;
• and evaluation of the parotid and submandibular glands in suspected Sjögren's disease.
Researchers also found that MSUS could be used to guide articular and peri-articular aspiration or injection at sites that include the synovial, tenosynovial, bursal, peritendinous and perientheseal areas.
Despite the benefits noted, the authors noted that they did not evaluate the economic impact of the procedure. McAlindon concluded, "Further study of the cost-effectiveness and long-term outcomes of MSUS is necessary to determine its value compared to other interventions."
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.